1Y Target$29.34Near-term target
5Y Target$41.08Compound horizon
10Y Target$60.39Long-dated conviction
FCF$1.8bTTM · 03/24C+FCF $1.8b — respectable but not differentiating · TTM computed from 4 most-recent quarters (TTM · 03/24).
Rev-12.7%TTM YoYDRevenue -12.7% — meaningful contraction · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E8.37FD/E 8.37 — extreme leverage (may reflect buyback-driven equity depletion; verify FCF strength)
P/E26.3xC+P/E 26.3 — elevated; requires sustained growth to justify
PEG—proxy—PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Energy · market cap $5.1b. Trading near 52-week high of $26.15 — momentum setup, limited technical margin of safety. Revenue -13% — in contraction; any catalyst that reverses this triggers re-rating.
Moat
ROE 15% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
D/E 8.37 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Revenue contracting -13% — the operational turn is not yet visible in the top line. Trading within 2% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
Horizon
1-3 yr $29.34 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $41.08 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $60.39 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.